Tandem Diabetes (NASDAQ: TNDM) exec nets 475 shares after RSU vesting
Rhea-AI Filing Summary
TANDEM DIABETES CARE INC (TNDM) executive Jean-Claude Kyrillos reported the vesting of restricted stock units and related share movements. On 2026-08-15, 1,010 RSUs granted on May 30, 2025 under the 2023 Long-Term Incentive Plan were converted into 1,010 shares of common stock. Of these, 535 shares were withheld by the company at $22.72 per share to satisfy tax withholding requirements, with no shares sold in the market, leaving a net 475 shares issued. Following the RSU vesting event, Kyrillos holds 7,067 RSUs that will continue to vest in eight equal quarterly installments, subject to the plan’s terms.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 475 shares
Net Buy
3 txns
Insider
Kyrillos Jean-Claude
Role
EVP & Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F2, F3, F4 | 1,010 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,010 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F1 | 535 | $22.72 | $12K |
Holdings After Transaction:
Restricted Stock Unit — 7,067 shares (Direct);
Common Stock — 30,290 shares (Direct)
Footnotes (4)
- F1. Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.
- F2. Awarded on May 30, 2025 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- F3. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- F4. One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
Key Figures
RSUs exercised/converted: 1,010 shares
Shares withheld for taxes: 535 shares
Withholding price: $22.72 per share
+2 more
5 metrics
RSUs exercised/converted
1,010 shares
Restricted Stock Units converted into common stock on 2026-08-15
Shares withheld for taxes
535 shares
Common stock withheld to satisfy tax withholding upon RSU vesting
Withholding price
$22.72 per share
Price used for shares withheld for tax liability (code F transaction)
Remaining RSUs
7,067 units
RSUs held after the vesting event reported in the derivative transaction
Net shares issued from vesting
475 shares
1,010 RSUs converted minus 535 shares withheld for taxes
Key Terms
Restricted Stock Unit, tax withholding requirements, Long-Term Incentive Plan, contingent right, +1 more
5 terms
Restricted Stock Unit financial
"security_title: "Restricted Stock Unit""
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax withholding requirements financial
"Shares withheld by the Issuer to satisfy tax withholding requirements"
Long-Term Incentive Plan financial
"pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan"
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
contingent right financial
"Each RSU represents a contingent right to receive either one share"
vested financial
"One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026"
FAQ
What insider equity transaction did TNDM executive Jean-Claude Kyrillos report?
Jean-Claude Kyrillos reported 1,010 restricted stock units vesting and converting into 1,010 TNDM common shares on 2026-08-15. The transaction reflects routine equity compensation vesting under Tandem Diabetes Care’s 2023 Long-Term Incentive Plan.
How many RSUs does Kyrillos still hold after this TNDM transaction?
After the reported vesting, Kyrillos holds 7,067 restricted stock units. According to the disclosure, one-third vested on May 15, 2026, and the remaining RSUs vest in eight equal quarterly installments, subject to the plan’s conditions.
What plan governs the RSU award reported in TNDM’s Form 4 for Kyrillos?
The RSUs were granted under Tandem Diabetes Care’s 2023 Long-Term Incentive Plan. The filing notes the award date as May 30, 2025 and that each RSU entitles Kyrillos to one share of common stock or cash, at the issuer’s discretion.
AI-generated analysis. How Rhea-AI works. Not financial advice.
